Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer? - Di Marco L; Valerio F; Maculan Y; Medici B; Spallanzani A; Dominici M; Ricci AD; Rizzo A; Salati M (Expert opinion on biological therapy, 2026)